Akshit Bansal, CEO of Statiq, noted, "In 2019, India led the global...
Category:
Facts
Latest
71% Indians not able to afford healthy diet: CSE Report
The diet of an average Indian lacks in fruits, vegetables, legumes,...
Breakthrough Covid infection more likely in cancer, Alzheimer’s patients
"This study showed significantly increased risks for Covid-19...
Covid-19 pandemic could push 130 mn more people into chronic hunger:UN
Preliminary projections based on available global economic outlooks suggest the pandemic may add an additional 83 (million) to 132 million people to the ranks of the undernourished in 2020,” the report said.
Antibody immunity to coronavirus may be short-lived: UK study
“This study has important implications when considering widespread serological testing, Ab protection against reinfection with SARS-CoV-2 and the durability of vaccine protection, the paper adds.
Touchless: How the world’s busiest airport envisions post-COVID travel
The Dallas airport is also testing new technology around better sanitization, beginning with ultraviolet technology that can kill germs before they circulate into the HVAC system.
Russia’s Sechenov University successfully completes clinical trials of Covid-19 vaccine
According to Alexander Lukashev, the director of the Institute of Medical Parasitology, Tropical and Vector-Borne Diseases at Sechenov University, the objective of this stage of the study was to show the vaccine’s safety for human health, which was successfully done.
Gilead analysis shows remdesivir reduced coronavirus death risk, more studies needed
Findings from the analysis showed that 74.4% of remdesivir-treated patients recovered by Day 14 versus 59.0% of patients receiving standard of care, the company said.
The mortality rate for patients treated with remdesivir in the analysis was 7.6% at Day 14, compared with 12.5% among patients not on remdesivir.
Relying on market forces for Covid-19 drugs would prolong the deadly pandemic:Bill Gates
With hundreds of vaccine projects under way and governments in Europe and the United States investing billions of dollars in research, trials and manufacturing, there is concern that richer nations could scoop up promising medicines against the new coronavirus, leaving developing countries empty-handed.
The European Commission and the World Health Organization have warned of an unhealthy competition in the scramble for a medicine seen as key to saving lives and resolving economic chaos sowed by virus, while some officials in Washington have indicated they would seek to prioritize U.S residents.
Biocon secures approval to use drug on coronavirus patients
“The randomised control trial indicated that all the patients treated with Itolizumab responded positively and recovered,” said Kiran Mazumdar-Shaw, the firm’s executive chairperson.
The control group which did not receive Itolizumab unfortunately suffered deaths, she said, adding that the “first-in-class” drug will save lives and help reduce the mortality rate in India.
U.S.bans Pakistan International Airlines flights over pilot concerns
Pakistan last month grounded almost a third of its pilots after discovering they may have falsified their qualifications.
The European Union Aviation Safety Agency suspended PIA’s authorisation to fly to the bloc for six months in a blow to the carrier’s operations.
Covid-19 left 147 mn unemployed, global consumption loss at $3.8 trn: Study
“Our study highlights the interconnected nature of international supply chains, with observable global spillover effects across a range of industry sectors, such as manufacturing, tourism and transport,” said study researcher Arunima Malik from the University of Sydney in Australia.
Tesla ‘very close’ to level 5 autonomous driving technology, Musk says
Tesla is also developing new heat projection or cooling systems to enable more advanced computers in cars, Musk said, hailing the company’s team in China for doing an “amazing job”.